Start-Up Previews (5/05)
Executive Summary
A preview of the emerging health care companies profiled in the current issue of Start-Up. This month's profile group, New Approaches to Heart Valve Repair and Replacement, features profiles of 3F Therapeutics, Arbor Surgical Technologies and Heart Leaflet Technologies. Plus these Start-Ups Across Health Care: Neotropix, NeuroHealing Pharmaceuticals, Othera Pharmaceuticals and Vitra Bioscience.
You may also be interested in...
The MPP And Merck Partner For Molnupiravir In Lower-Income Countries
The Medicines Patent Pool has signed its first agreement to provide access for a COVID-19 medical technology with Merck & Co, to increase access of generic molnupiravir to 150 lower income countries.
Industry Leaders Call For Legal Certainty On Northern Ireland Regulation
The European Commission’s proposals for solving the post-Brexit regulatory problems relating to the Northern Ireland market are welcome but they do not go far enough and risk leaving suppliers in a legal limbo, says the off-patent medicines industry.
NIH Study Keeps Synairgen’s Dream Of An Inhaled COVID-19 Therapy Alive
SNG001 has moved into a Phase III open label trial in which it must prove its non-inferiority against Regeneron's monoclonal antibody cocktail.